Alaris infusion pump recalledJuly 23, 2019A manufacturing oversight has resulted in an FDA Class I recall of more than half a million infusion pumps across the U.S.
Education Center - SponsoredRethinking Our Approach to Canine OA: Treating synovial inflammationby • Exubrion TherapeuticsIt’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
